A Proposed Methodology for a Risk Assessment-Based Liposome Development Process
The requirements of a liposomal formulation vary depending on the pharmaceutical indication, the target patient population, and the corresponding route of administration. Different preparation methods require various material attributes (MAs) (properties and characteristics of the components) and pr...
Saved in:
Main Authors: | Zsófia Németh (Author), Edina Pallagi (Author), Dorina Gabriella Dobó (Author), Ildikó Csóka (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development
by: Zsófia Németh, et al.
Published: (2021) -
Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives
by: Zsófia Németh, et al.
Published: (2022) -
Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration
by: Bence Sipos, et al.
Published: (2020) -
A Systematic, Knowledge Space-Based Proposal on Quality by Design-Driven Polymeric Micelle Development
by: Bence Sipos, et al.
Published: (2021) -
Risk-Assessment-Based Optimization Favours the Development of Albumin Nanoparticles with Proper Characteristics Prior to Drug Loading
by: Gábor Katona, et al.
Published: (2022)